Bioactive adrenomedullin, proenkephalin A and clinical outcomes in an acute heart failure setting

OBJECTIVES: In an acute heart failure (AHF) setting, proenkephalin A 119–159 (penKid) has emerged as a promising prognostic marker for predicting worsening renal function (WRF), while bioactive adrenomedullin (bio-ADM) has been proposed as a potential marker for congestion. We examined the diagnosti...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Open Heart
Hlavní autoři: Molvin, John, Jujic, Amra, Navarin, Silvia, Melander, Olle, Zoccoli, Giada, Hartmann, Oliver, Bergmann, Andreas, Struck, Joachim, Bachus, Erasmus, Di Somma, Salvatore, Magnusson, Martin
Médium: Artigo
Jazyk:Inglês
Vydáno: BMJ Publishing Group 2019
Témata:
Heart Failure and Cardiomyopathies
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6615850/
https://ncbi.nlm.nih.gov/pubmed/31354956
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/openhrt-2019-001048
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky